85 related articles for article (PubMed ID: 24376277)
1. Effect of cessation interventions on hookah smoking: post-hoc analysis of a cluster-randomized controlled trial.
Dogar O; Jawad M; Shah SK; Newell JN; Kanaan M; Khan MA; Siddiqi K
Nicotine Tob Res; 2014 Jun; 16(6):682-8. PubMed ID: 24376277
[TBL] [Abstract][Full Text] [Related]
2. Action to stop smoking in suspected tuberculosis (ASSIST) in Pakistan: a cluster randomized, controlled trial.
Siddiqi K; Khan A; Ahmad M; Dogar O; Kanaan M; Newell JN; Thomson H
Ann Intern Med; 2013 May; 158(9):667-75. PubMed ID: 23648948
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of varenicline in achieving abstinence among waterpipe tobacco smokers - study protocol for a randomized controlled trial.
Zahid R; Dogar O; Mansoor S; Khan A; Kanaan M; Jawad M; Ahluwalia JS; Siddiqi K
Trials; 2017 Jan; 18(1):14. PubMed ID: 28077163
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Cabezas C; Advani M; Puente D; Rodriguez-Blanco T; Martin C;
Addiction; 2011 Sep; 106(9):1696-706. PubMed ID: 21561497
[TBL] [Abstract][Full Text] [Related]
6. Predictors of cessation in smokers suspected of TB: Secondary analysis of data from a cluster randomized controlled trial.
Elsey H; Dogar O; Ahluwalia J; Siddiqi K
Drug Alcohol Depend; 2015 Oct; 155():128-33. PubMed ID: 26297296
[TBL] [Abstract][Full Text] [Related]
7. A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation.
Zernig G; Wallner R; Grohs U; Kriechbaum N; Kemmler G; Saria A
Addiction; 2008 Dec; 103(12):2024-31. PubMed ID: 19469746
[TBL] [Abstract][Full Text] [Related]
8. Combination Extended Smoking Cessation Treatment Plus Home Visits for Smokers With Schizophrenia: A Randomized Controlled Trial.
Brody AL; Zorick T; Hubert R; Hellemann GS; Balali S; Kawasaki SS; Garcia LY; Enoki R; Abraham P; Young P; McCreary C
Nicotine Tob Res; 2017 Jan; 19(1):68-76. PubMed ID: 27613888
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Smoking Cessation Interventions in Patients With Cardiovascular Disease: A Network Meta-Analysis of Randomized Controlled Trials.
Suissa K; Larivière J; Eisenberg MJ; Eberg M; Gore GC; Grad R; Joseph L; Reynier PM; Filion KB
Circ Cardiovasc Qual Outcomes; 2017 Jan; 10(1):. PubMed ID: 28093398
[TBL] [Abstract][Full Text] [Related]
10. Predictors of success for smoking cessation at the workplace: a longitudinal study.
Stolz D; Scherr A; Seiffert B; Kuster M; Meyer A; Fagerström KO; Tamm M
Respiration; 2014; 87(1):18-25. PubMed ID: 23594795
[TBL] [Abstract][Full Text] [Related]
11. Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis.
Weiner E; Ball MP; Buchholz AS; Gold JM; Evins AE; McMahon RP; Buchanan RW
J Clin Psychiatry; 2012 Jan; 73(1):95-102. PubMed ID: 21535998
[TBL] [Abstract][Full Text] [Related]
12. Intensive smoking cessation intervention reduces mortality in high-risk smokers with cardiovascular disease.
Mohiuddin SM; Mooss AN; Hunter CB; Grollmes TL; Cloutier DA; Hilleman DE
Chest; 2007 Feb; 131(2):446-52. PubMed ID: 17296646
[TBL] [Abstract][Full Text] [Related]
13. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.
Walker N; Howe C; Bullen C; Grigg M; Glover M; McRobbie H; Laugesen M; Parag V; Whittaker R
Addiction; 2012 Oct; 107(10):1857-67. PubMed ID: 22594651
[TBL] [Abstract][Full Text] [Related]
14. If at first you don't succeed: characterization of smokers with late smoking abstinence onset.
Leyro TM; Hendricks PS; Hall SM
Addict Behav; 2015 Jun; 45():34-8. PubMed ID: 25637886
[TBL] [Abstract][Full Text] [Related]
15. A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia.
Evins AE; Cather C; Culhane MA; Birnbaum A; Horowitz J; Hsieh E; Freudenreich O; Henderson DC; Schoenfeld DA; Rigotti NA; Goff DC
J Clin Psychopharmacol; 2007 Aug; 27(4):380-6. PubMed ID: 17632223
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE; Hays JT; Rigotti NA; Azoulay S; Watsky EJ; Williams KE; Billing CB; Gong J; Reeves KR;
JAMA; 2006 Jul; 296(1):56-63. PubMed ID: 16820547
[TBL] [Abstract][Full Text] [Related]
17. Smoking cessation intervention: an evidence-based approach.
Laniado-Laborín R
Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
[TBL] [Abstract][Full Text] [Related]
18. A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
Toll BA; Leary V; Wu R; Salovey P; Meandzija B; O'Malley SS
Addict Behav; 2008 Jan; 33(1):173-9. PubMed ID: 17587504
[TBL] [Abstract][Full Text] [Related]
19. Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation.
Gifford EV; Kohlenberg BS; Hayes SC; Pierson HM; Piasecki MP; Antonuccio DO; Palm KM
Behav Ther; 2011 Dec; 42(4):700-15. PubMed ID: 22035998
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
